May 7 (Reuters) - Akari Therapeutics PLC AKTX.O :
* AKARI THERAPEUTICS PLC - ON MAY 1 BEGAN TO IMPLEMENT A
REDUCTION-IN-FORCE OF APPROXIMATELY 67% OF ITS TOTAL WORKFORCE
* AKARI THERAPEUTICS PLC - REDUCTION-IN-FORCE IS PART OF
OPERATIONAL RESTRUCTURING PLAN AND INCLUDES ELIMINATION OF
CERTAIN SENIOR MANAGEMENT POSITIONS
* AKARI THERAPEUTICS PLC - RACHELLE JACQUES RESIGNED FROM
BOARD
OF DIRECTORS
* AKARI THERAPEUTICS PLC - BOARD REDUCED ITS SIZE TO FIVE
MEMBERS
* AKARI THERAPEUTICS PLC - EXPECTS EXPENSES RELATED TO
REDUCTION-IN-FORCE TO BE IN RANGE OF ABOUT $3.1 MILLION TO $3.2
MILLION
Source text for Eikon: ID:n0000950170-24-054726
Further company coverage: AKTX.O